Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Osteoporosis Drugs Market to reach USD 12.13 billion by the end of 2030

Global Osteoporosis Drugs Market Size Study & Forecast, by Drug Type (Parathyroid Hormone Therapy, Bisphosphonates, Calcitonin, RANKL Inhibitors, Other Drug Types), by Route of Administration (Oral, Injectable, Others), and Regional Analysis, 2023-2030

Product Code: HLSDT-26848785
Publish Date: 27-06-2023
Page: 200

Global Osteoporosis Drugs Market is valued at approximately USD 8.93 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 3.9% over the forecast period 2023-2030. Osteoporosis is a medical condition that is characterized by low bone quality and density in humans. Additionally, this health issue causes the bones to become porous, which makes them more brittle and susceptible to fractures. The disorder is caused by an excess of the hormone parathyroid. The condition results in serious fractures, which are harmful to the patient’s health. Because of this, the problem needs to be treated, which involves taking medications for osteoporosis. RANK ligand inhibitors, parathyroid hormone treatment, calcitonin, and selective estrogen inhibitors modulators (SERM) are several medications available in the market. These medications are administered in ways including orally and intravenously. The surge in the geriatric population, adoption of a sedentary lifestyle, increasing healthcare expenditure, and rise in hip fractures are the several factors that are propelling the market demand during the estimated period.

In addition, the increase in the incidences of osteoporosis is playing a major role that is stipulating market growth across the globe. The prevalence of osteoporosis is increasing due to changing lifestyle habits, lack of physical activity, and poor diet. This has led to an increase in the demand for osteoporosis drugs. The International Osteoporosis Foundation stated that in 2020, 1 in 5 men and 1 in 3 women more than the age of 50 are likely to experience osteoporosis fractures in their life. Additionally, according to the International Osteoporosis Foundation (IOF), in 2019, the annual number of osteoporotic fractures in Europe accounted for 4.28 million, which is projected to increase and reach 5.34 million in 2034. The percentage growth during the 15-year period is likely to differ significantly by nation, from a low 8% growth (Latvia) to 58% (Ireland). Also, as per the National Osteoporosis Foundation (NOF), in 2020, over 10 million people in the United States have been diagnosed with osteoporosis, which is common in menopausal women. Consequentially, the rising cases of osteoporosis are significantly contributing to the market expansion. Moreover, the high growth prospects in emerging markets, as well as the increasing investment in R&D activities present various lucrative opportunities over the forecasting years. However, the stringent regulations on the drug approval process and the side effects of osteoporosis drugs are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Osteoporosis Drugs Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the surge in the incidence of osteoporosis, the presence of key players, and growing R&D investment. Whereas, Asia Pacific is expected to grow at the fastest growing over the forecasting years. The growing awareness regarding the use of osteoporosis drugs, rising government initiatives, increase in hip fractures, changing lifestyle, and growing demand for generic drugs are significantly propelling the market demand across the region.

Major market players included in this report are:
Amgen Inc.
Eli Lilly and Company
F. HOFFMANN-LA ROCHE LTD.
Radius Health, Inc.
Merck & Co. Inc.
Novartis International AG (Sandoz)
Pfizer Inc.
Sun Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
Teva Pharmaceutical Industries Ltd.

Recent Developments in the Market:
Ø In August 2021, The Drug Controller General of India (DCGI) granted Enzene Biosciences Ltd. marketing authorization (MA) for their biosimilar medication, denosumab, which is approved for the treatment of adult osteoporosis.

Global Osteoporosis Drugs Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Drug Type, Route of Administration, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Type:
Parathyroid Hormone Therapy
Bisphosphonates
Calcitonin
RANKL Inhibitors
Other Drug Types

By Route of Administration:
Oral
Injectable
Others

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Osteoporosis Drugs Market, by Region, 2020-2030 (USD Billion)
1.2.2. Osteoporosis Drugs Market, by Drug Type, 2020-2030 (USD Billion)
1.2.3. Osteoporosis Drugs Market, by Route of Administration, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Osteoporosis Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Osteoporosis Drugs Market Dynamics
3.1. Osteoporosis Drugs Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increase in the incidences of osteoporosis
3.1.1.2. Rising hip fractures
3.1.2. Market Challenges
3.1.2.1. Stringent regulations on drug approval process
3.1.2.2. Side effects of osteoporosis drugs
3.1.3. Market Opportunities
3.1.3.1. High growth prospects in emerging markets
3.1.3.2. Increasing investment in the R&D activities
Chapter 4. Global Osteoporosis Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Osteoporosis Drugs Market, by Drug Type
5.1. Market Snapshot
5.2. Global Osteoporosis Drugs Market by Drug Type, Performance – Potential Analysis
5.3. Global Osteoporosis Drugs Market Estimates & Forecasts by Drug Type 2020-2030 (USD Billion)
5.4. Osteoporosis Drugs Market, Sub Segment Analysis
5.4.1. Parathyroid Hormone Therapy
5.4.2. Bisphosphonates
5.4.3. Calcitonin
5.4.4. RANKL Inhibitors
5.4.5. Other Drug Types
Chapter 6. Global Osteoporosis Drugs Market, by Route of Administration
6.1. Market Snapshot
6.2. Global Osteoporosis Drugs Market by Route of Administration, Performance – Potential Analysis
6.3. Global Osteoporosis Drugs Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
6.4. Osteoporosis Drugs Market, Sub Segment Analysis
6.4.1. Oral
6.4.2. Injectable
6.4.3. Others
Chapter 7. Global Osteoporosis Drugs Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Osteoporosis Drugs Market, Regional Market Snapshot
7.4. North America Osteoporosis Drugs Market
7.4.1. U.S. Osteoporosis Drugs Market
7.4.1.1. Drug Type breakdown estimates & forecasts, 2020-2030
7.4.1.2. Route of Administration breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Osteoporosis Drugs Market
7.5. Europe Osteoporosis Drugs Market Snapshot
7.5.1. U.K. Osteoporosis Drugs Market
7.5.2. Germany Osteoporosis Drugs Market
7.5.3. France Osteoporosis Drugs Market
7.5.4. Spain Osteoporosis Drugs Market
7.5.5. Italy Osteoporosis Drugs Market
7.5.6. Rest of Europe Osteoporosis Drugs Market
7.6. Asia-Pacific Osteoporosis Drugs Market Snapshot
7.6.1. China Osteoporosis Drugs Market
7.6.2. India Osteoporosis Drugs Market
7.6.3. Japan Osteoporosis Drugs Market
7.6.4. Australia Osteoporosis Drugs Market
7.6.5. South Korea Osteoporosis Drugs Market
7.6.6. Rest of Asia Pacific Osteoporosis Drugs Market
7.7. Latin America Osteoporosis Drugs Market Snapshot
7.7.1. Brazil Osteoporosis Drugs Market
7.7.2. Mexico Osteoporosis Drugs Market
7.8. Middle East & Africa Osteoporosis Drugs Market
7.8.1. Saudi Arabia Osteoporosis Drugs Market
7.8.2. South Africa Osteoporosis Drugs Market
7.8.3. Rest of Middle East & Africa Osteoporosis Drugs Market

Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Amgen Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Recent Developments
8.3.2. Eli Lilly and Company
8.3.3. F. HOFFMANN-LA ROCHE LTD.
8.3.4. Radius Health, Inc.
8.3.5. Merck & Co. Inc.
8.3.6. Novartis International AG (Sandoz)
8.3.7. Pfizer Inc.
8.3.8. Sun Pharmaceutical Industries Ltd.
8.3.9. Takeda Pharmaceutical Company Limited
8.3.10. Teva Pharmaceutical Industries Ltd.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now